Skin Patch Shows Promise for Toddlers with Peanut Allergy

A global phase 3 clinical trial that included Ann & Robert H. Lurie Children’s Hospital of Chicago found that a year-long immunotherapy through a skin patch safely desensitized toddlers with peanut allergy, lowering the risk of a severe allergic reaction from accidental exposure. Results of this randomized, double-blind, placebo-controlled trial for children 1-3 years of age, funded by DBV Technologies, were published in the New England Journal of Medicine.

Four Years After Release of Guidelines, Parents Still Not Informed About Early Peanut Introduction

A new study being presented at this year’s ACAAI Annual Scientific Meeting reveals that although 58% of those surveyed reported their primary care physician discussed early peanut introduction, only 40% of the parents said they received a recommendation to introduce peanut by 11 months of age.

Experts Question Need to Wait Days Between Introducing New Solid Foods to Infants

The current recommendations from the American Academy of Pediatrics (AAP) and the Centers for Disease Control and Prevention (CDC) call for introducing to infants one single-ingredient food at a time and waiting three to five days to observe for food allergy before introducing another new food. However, the long waiting period might be too long, given that food allergy becomes apparent within minutes to a few hours after eating a new food. A recent survey of pediatricians, published in JAMA Network Open, found significant variability in their recommendations to parents about solid food introduction, which calls into question the relevance of the current guidelines.

Therapy Helps Children with Food Allergies Manage Severe Anxiety

Children’s Hospital of Philadelphia (CHOP) has launched the Food Allergy Bravery (FAB) Clinic to help children with a phobia of anaphylaxis. This revolutionary clinic, housed within the Food Allergy Center, is the first in the world to bring together psychologists and food allergy experts to treat food allergic children with severe phobia of anaphylaxis.

Food Allergy May Be Underdiagnosed in Children on Medicaid

Prevalence of food allergy among Medicaid-enrolled children across the U.S. was substantially lower (0.6 percent), compared to previous national estimates using parent surveys (7.6 percent) and reports of physician confirmation of food allergy (4.7 percent). The study, published in Academic Pediatrics, was the first to analyze Medicaid claims data of over 23 million children to estimate prevalence of food allergy diagnosis.

Children with Food Protein-Induced Enterocolitis More Likely to Have Other Allergies

Researchers at Children’s Hospital of Philadelphia (CHOP) have found that children with a rare food allergy known as food protein-induced enterocolitis syndrome, or FPIES, have a significantly higher chance of being diagnosed with other allergic conditions, including eczema, traditional food allergy and asthma. But the researchers also found that FPIES did not directly cause those other allergies.

New FDA-Approved Oral Immunotherapy Marks Important Milestone in Peanut Allergy Management

The U.S. Food and Drug Administration (FDA) approved Palforzia, a peanut powder product designed to help reduce peanut-induced allergic reactions.

Although Palforzia just received FDA approval, Nuvance Health allergists/immunologists have been offering oral immunotherapy (OIT) for various food allergies for five years.

By slowly increasing a person’s tolerance to an allergen over time, OIT can lower the risk of having a severe allergic reaction. This lowered risk may help reduce anxiety for kids with food allergies, as well as their family members and caregivers.